Archives for October 5, 2005

← 2005

FDA deputy adds flesh to bones of new labelling regs

New rules detailing an improved format for prescription drug labels will be issued later this year, US Food and Drug Administration deputy commissioner for medical and scientific affairs Scott Gottlieb has said.

High-throughput dose inspection system launched

Key Technology subsidiary Symetix has launched a new inspection system fortablets, capsules, and softgels called Vantyx that it claims can achieve 100 percent, in-line inspection at full production speeds.

Invitrogen buys into nanotechnology as R&D tool

Invitrogen has announced two additional acquisitions in the area of nanotechnologcal tools for target and drug discovery, just as it completes the earlier-announced purchase of Biosource International.

Valois opens pilot unit for inhaled drugs

The pharmaceutical division of French packaging company Valois has completed construction of a pilot filling and packaging unit based at its site in Le Vaudreuil in the Eure area of France, dedicated to the production of pressurised medicinal...

Biotage completes distribution restructuring

Sweden's Biotage, a specialist in microwave synthesis and chromatography systems for drug development and production, has taken some of its European distribution into its own hands through the purchase of Separtis Holding.

PET scans are early warning system for Alzheimer's

Positron emission tomography (PET) imaging with the radiotracer fluorodeoxyglucose (FDG) could be used to detect Alzheimer's disease in patients who have mild cognitive impairment, according to a study reported in the October issue of the Society of...

UK researchers move closer to Group B Strep vaccine

Microbiologists from the University of Bradford in the UK believe they may be closer to developing a vaccine that can protect newborn babies from being infected by the common and potentially fatal bacteria Group B Streptococcus.

Nutrition at core of DSM innovation plan

By  Dominique Patton

Innovation in targeted areas like nutrition should add sales worth €1 billion in five years time, said vitamin and specialty chemicals maker DSM today.